Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("FOX, Kim")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 71

  • Page / 3
Export

Selection :

  • and

New results with ivabradineFOX, Kim.European heart journal supplements. 2009, Vol 11, Num D, issn 1520-765X, D2-D7Conference Paper

Benefits of perindopril all along the cardiovascular continuum : the level of evidenceFOX, Kim.European heart journal supplements. 2008, Vol 10, Num G, issn 1520-765X, G4-G12Conference Paper

Contribution of perindopril to cardiology : 20 years of successFOX, Kim.European heart journal supplements. 2007, Vol 9E, issn 1520-765X, E10-E19Conference Paper

Ivabradine: advantages throughout the cardiovascular continuumFOX, Kim.European heart journal supplements. 2010, Vol 12, Num C, issn 1520-765X, c16-c20Conference Paper

Insight into the Mode of Action of ACE Inhibition in Coronary Artery Disease : The Ultimate 'EUROPA' StoryFERRARI, Roberto; FOX, Kim.Drugs (Basel). 2009, Vol 69, Num 3, pp 265-277, issn 0012-6667, 13 p.Article

The EUROPA trial: Design, baseline demography and status of the substudiesCOMMA, Abba H; FOX, Kim M.Cardiovascular drugs and therapy. 2001, Vol 15, Num 2, pp 169-179, issn 0920-3206Article

Current status: heart rate as a treatable risk factorFOX, Kim M.European heart journal supplements. 2011, Vol 13, Num C, issn 1520-765X, C30-C36Conference Paper

Fashioning a new approach to coronary care in womenNAIDOO, Vahini V; FOX, Kim M.Heart. Supplement. 2006, Vol 92, Num 3, 31 p.Conference Proceedings

Risk factors for cardiovascular disease and hormone therapy in womenCOLLINS, P.Heart. Supplement. 2006, Vol 92, Num 3, iii24-iii28Conference Paper

Silent myocardial ischemiaCOHN, Peter F; FOX, Kim M; DALY, Caroline et al.Circulation (New York, N.Y.). 2003, Vol 108, Num 10, pp 1263-1277, issn 0009-7322, 15 p.Article

Relationship between discharge heart rate and mortality in patients after acute myocardial infarction treated with primary percutaneous coronary interventionLOUISA ANTONI, M; BODEN, Helèn; DELGADO, Victoria et al.European heart journal. 2012, Vol 33, Num 1, pp 96-102, issn 0195-668X, 7 p.Article

Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction : the morBidity-mortality EvAIUuaTion of the if inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) StudyFOX, Kim; FERRARI, Roberto; TENDERA, Michal et al.The American heart journal. 2006, Vol 152, Num 5, pp 860-866, issn 0002-8703, 7 p.Article

A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosisHAMANN, Lutz; GOMMA, Abuzeid; SCHRÖDER, Nicolas W. J et al.Journal of molecular medicine (Berlin. Print). 2005, Vol 83, Num 6, pp 478-485, issn 0946-2716, 8 p.Article

Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registryTENDERA, Michal; FOX, Kim; STEG, P. Gabriel et al.International journal of cardiology. 2014, Vol 176, Num 1, pp 119-124, issn 0167-5273, 6 p.Article

Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA studyBRIGGS, Andrew; MIHAYLOVA, Borislava; FOX, Kim et al.Heart (London 1996). 2007, Vol 93, Num 9, pp 1081-1086, issn 1355-6037, 6 p.Article

The Cardioprotective Effects of the Angiotensin-Converting Enzyme Inhibitor Perindopril in Patients With Stable Coronary Artery Disease Are Not Modified by Mild to Moderate Renal Insufficiency : Insights From the EUROPA TrialBRUGTS, Jasper J; BOERSMA, Eric; CHONCHOL, Michel et al.Journal of the American College of Cardiology. 2007, Vol 50, Num 22, pp 2148-2155, issn 0735-1097, 8 p.Article

Antianginal and antiischemic effects of ivabradine, an Ifinhibitor, in stable angina: A randomized, double-blind, multicentered, placebo-controlled trialBORER, Jeffrey S; FOX, Kim; JAILLON, Patrice et al.Circulation (New York, N.Y.). 2003, Vol 107, Num 6, pp 817-823, issn 0009-7322, 7 p.Article

The wealth of nations and the dissemination of cardiovascular researchWINNIK, Stephan; SPEER, Timo; VAN DE WERF, Frans et al.International journal of cardiology. 2013, Vol 169, Num 3, pp 190-195, issn 0167-5273, 6 p.Article

Differences in presentation and management of Stable Angina from East to West in Europe : A comparison between Poland and the UKDALY, Caroline Ann; STEPINSKA, Janina; DEPTUCH, Tomasz et al.International journal of cardiology. 2008, Vol 125, Num 3, pp 311-318, issn 0167-5273, 8 p.Article

Resting heart rate in cardiovascular diseaseFOX, Kim; BORER, Jeffrey S; CAMM, A. John et al.Journal of the American College of Cardiology. 2007, Vol 50, Num 9, pp 823-830, issn 0735-1097, 8 p.Article

Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function?FOX, Kim; FERRARI, Roberto; YUSUF, Salim et al.European heart journal. 2006, Vol 27, Num 18, pp 2154-2157, issn 0195-668X, 4 p.Article

Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158 998 patientsVARK, Laura C. Van; BERTRAND, Michel; MARTIJN AKKERHUIS, K et al.European heart journal. 2012, Vol 33, Num 16, pp 2088-2097, issn 0195-668X, 10 p.Article

Cardiovascular Mortality and Heart Failure Risk Score for Patients After ST-Segment Elevation Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (Data from the Leiden MISSION! Infarct Registry)LOUISA ANTONI, M; HOOGSLAG, Georgette E; BODEN, Helen et al.The American journal of cardiology. 2012, Vol 109, Num 2, pp 187-194, issn 0002-9149, 8 p.Article

Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trialFOX, Kim; FORD, Ian; GABRIEL STEG, Ph et al.European heart journal. 2009, Vol 30, Num 19, pp 2337-2345, issn 0195-668X, 9 p.Article

A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individualsBRUGTS, Jasper J; ISAACS, Aaron; REMME, Willem et al.Journal of hypertension. 2011, Vol 29, Num 3, pp 509-519, issn 0263-6352, 11 p.Article

  • Page / 3